The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Man­u­fac­tur­ing roundup: Juno Phar­ma­ceu­ti­cals ac­quires Omega Lab­o­ra­to­ries; Pfiz­er halts dis­tri­b­u­tion of four med­i­cines

3 years ago

Man­u­fac­tur­ing-cen­tric SPAC makes a deal to com­bine with French CD­MO

3 years ago
Deals

Mus­tang Bio to sell Mass­a­chu­setts CAR-T man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Deals
Cell/Gene Tx

EMA makes rec­om­men­da­tions to man­u­fac­tur­ers as it aims to stem drug short­ages

3 years ago
Pharma

Post-re­call, OTC eye drop mak­er hand­ed a warn­ing let­ter from the FDA

3 years ago
Pharma

Ip­ca Lab­o­ra­to­ries cit­ed for qual­i­ty is­sues at In­dia fa­cil­i­ty that pro­duces API

3 years ago
Pharma

House com­mit­tee holds hear­ing to iden­ti­fy root caus­es of re­cent drug short­ages

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Qual­i­ty is­sues at Sun Phar­ma plant in In­dia; Forge se­cures gene ther­a­py man­u­fac­tur­ing con­tract

3 years ago

AAV pro­duc­er New­Bi­ologix emerges from stealth with $50M Se­ries A

3 years ago
Pharma
Cell/Gene Tx

CRO deal space con­tin­ues to buzz as Gen­e­sis Drug Dis­cov­ery buys JSS Med­ical Re­search

3 years ago
Deals
Outsourcing

CRO Sy­neos Health to be ac­quired by a group of pri­vate eq­ui­ty firms for $7B+

3 years ago
Deals
Outsourcing

Af­ter warn­ing let­ters and fa­tal poi­son­ings, FDA is­sues guid­ance for strin­gent test­ing of con­t­a­m­i­nants

3 years ago
Pharma
FDA+

As­cend launch­es with $130M+ as it looks to build in the AAV space

3 years ago
Cell/Gene Tx

Eu­rope looks to shore up med­i­cines sup­ply amid short­ages

3 years ago

Bio­Phar­ma So­lu­tions sold for $4B+ to two pri­vate eq­ui­ty firms

3 years ago
Deals
Pharma

Catal­ent de­lays quar­ter­ly call as stock takes an­oth­er dive

3 years ago
Pharma

FDA again re­quests com­ments on ni­trosamine im­pu­ri­ties in drugs

3 years ago
FDA+

Ex­plo­sion re­port­ed at Se­qens API man­u­fac­tur­ing plant in Mass­a­chu­setts, caus­ing one death

3 years ago

On heels of Es­sex deal, CRO Emmes says it's plan­ning to make more ac­qui­si­tions this year

3 years ago
Deals
Outsourcing

Man­u­fac­tur­ing roundup: Mer­ck KGaA plans new fa­cil­i­ty in South Ko­rea; Dae­woong in­vests $75M in­to new plant for Botox ri­val

3 years ago

Te­va is­sues re­call of fen­tanyl buc­cal tablets over la­bel­ing is­sue

3 years ago

Forge Bi­o­log­ics se­cures man­u­fac­tur­ing and de­vel­op­ment deal with Lab­Corp

3 years ago
Deals
Pharma

FDA cites qual­i­ty is­sues at Rentschler and Eli Lil­ly fa­cil­i­ties

3 years ago
Pharma
FDA+

Boehringer In­gel­heim to con­struct a $300M+ fa­cil­i­ty at its HQ

3 years ago
R&D
First page Previous page 31323334353637 Next page Last page
A service from the Financial Times